---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-024634"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2022-10-24T23:59:59+00:00"
generated_at: "2026-06-23T01:33:04.290910+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Integrated BioPharma dismisses Friedman LLP and appoints Marcum LLP as auditor after merger

## Summary
- Friedman LLP combined with Marcum LLP effective September 1, 2022, then operated separately for Integrated BioPharma.
- On October 21, 2022, the Audit Committee ratified the dismissal of Friedman and engagement of Marcum.
- No disagreements or reportable events occurred in the two most recent fiscal years or subsequent interim period.
- Friedman's audit reports for FY2022 and FY2021 were unqualified and not modified as to uncertainty or scope.

## SEC filing metadata
- accession: 0001437749-22-024634
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2022-10-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774922024634/0001437749-22-024634-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774922024634/inbp20221024_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-024634
- JSON: https://secwatch.observer/filing/0001437749-22-024634.json
- Plain text: https://secwatch.observer/filing/0001437749-22-024634.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.